Health
Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis – News-Medical.net
Human dihydroorotate dehydrogenase(DHODH) is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis(RA),…
Human dihydroorotate dehydrogenase(DHODH) is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis(RA), psoriasis andmultiple sclerosis(MS).
The authors designed and synthesized a series of acrylamide-based novel DHODH inhibitors as potential RA treatment agents. 2-Acrylamidobenzoic acid analog11was identified as the lead compound for structure-activity relationship (SAR) studies.
The replacement of thephenyl group with naphthylmoieties…
-
Noosa News10 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General14 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General13 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba
-
Business18 hours agoCSL stock has been falling: bargain or beware?